Stryker considers its MAKO robotic surgery system and its clot removal devices as growth accelerators for the company through 2016. The artificial knee and hip implants maker is also cautiously eyeing more M&A targets after it recently acquired a number of assets.
In a recent conference call with investors, Stryker reported that the company delivered 20 MAKO robots in Q4 last year and nine during the first quarter, for both existing customers and competitive accounts. A slight supply disruption is expected to be resolved by the second quarter, and will not hinder momentum.
Help employers find you! Check out all the jobs and post your resume.
In a recent conference call with investors, Stryker reported that the company delivered 20 MAKO robots in Q4 last year and nine during the first quarter, for both existing customers and competitive accounts. A slight supply disruption is expected to be resolved by the second quarter, and will not hinder momentum.
Help employers find you! Check out all the jobs and post your resume.
